Studies have shown that abnormal low-density lipoprotein receptor expression significantly inhibits the Shc/MEK/ERK pathway in chronic cerebral ischemia (CCH) models, leading to OL death after CCH [36]. The gene discussed is MAP2K7; the disease is columnar cell hyperplasia of the breast.